Cigna Ventures leads $29.5M investment in healthcare analytics company

Healthcare analytics company Arcadia raised $29.5 million in new funding. The growth capital round was led by Cigna Ventures, with participation from past investors. Burlington, Massachusetts-based Arcadia integrates with more than 40 different electronic health record companies. It aggregates and analyzes records data to help hospitals and accountable care organizations meet metrics for value-based care. The company also develops tools to identify gaps in patient care and find ways to improve on cost. Arcadia is accelerating the path to value-based care through its use of high-quality data, sophisticated analytics and workflow technology” Tom Richards, global lead of strategy and business development at Cigna Ventures, said in a news release. Cigna has a long history of partnering with innovative companies who, like us, are focused on making health care affordable, predictable and simple and improving health and well-being outcomes. Arcadia not only shares that vision, but with our investment and partnership, can bring even more resources and tools to health care professionals enhancing patient care and furthering the adoption of value-based care models.

Spotlight

Spotlight

Related News

Health Technology, Digital Healthcare

Oracle Helps Medical Entities Handle Financial and Supply Chain Issues

Oracle | September 20, 2023

The Oracle Fusion Cloud Applications Suite offers healthcare-specific functionalities enabling entities to streamline operations and enhance patient outcomes. The conference highlights the need for healthcare organizations to prioritize transparency and collaboration across the entire delivery system, including suppliers, payers, and patient invoicing. As healthcare increasingly prioritizes proactive patient care, enhanced integration and collaboration across the ecosystem are vital for greater efficiency, accessibility, and equity. During the Oracle Health Conference, Oracle introduced specialized healthcare features into its Oracle Fusion Cloud Enterprise Resource Planning (ERP), Oracle Fusion Cloud Enterprise Performance Management (EPM), and Oracle Fusion Cloud Supply Chain and Manufacturing (SCM) solutions to assist healthcare organizations in improving patient care. The healthcare-specific functionalities have been integrated into the Oracle Fusion Cloud Applications Suite to assist healthcare organizations in enhancing financial transparency, fortifying supply chains, and elevating patient care. These will also help empower healthcare organizations to boost efficiency, reduce costs, adapt to new business models, improve decision-making processes, and enhance patient services. Nevertheless, the healthcare sector faces significant hurdles due to unpredictable demand and increased administrative costs. These challenges include managing resource and supply shortages and adapting to changing financial requirements for patient care. These difficulties have arisen when the demand for efficient and accessible healthcare is more critical than ever. The newly introduced capabilities within Oracle's healthcare-specific solutions empower healthcare organizations to streamline operations and adapt to evolving healthcare delivery models, from telehealth to home and community-based care. These enhancements encompass vital areas, including financial consolidation and reporting, which provide healthcare organizations with the tools to maintain comprehensive financial oversight in a complex healthcare environment through AI and automation. In procurement, these capabilities help reduce expenses and enhance the efficiency of medical supply orders, including contract and pricing integrations with group purchasing capabilities. Furthermore, replenishment planning and recall management features improve the availability of medical supplies by predicting demand and facilitating efficient recall processes to enhance safety and reduce risks within the healthcare supply chain. Steve Miranda, Executive Vice President of Applications Development at Oracle, stated, The new capabilities added to Oracle Fusion Applications Suite will help healthcare organizations adopt new business models, embrace rapid innovation, build agile and sustainable supply chains, and better serve patients' needs—now and in the future. [Source: Cision PR Newswire] The Oracle Fusion Applications Suite will empower organizations to leverage cloud technology for dismantling internal barriers, standardizing operations, and centralizing financial, HR, supply chain, and customer experience data within a unified cloud platform. Through quarterly update cycles, customers can continuously access the latest innovations as new capabilities are regularly incorporated.

Read More

Healthcare Analytics

GE HealthCare Releases Sustainability Report, Shares Future Goals

GE HealthCare | September 25, 2023

First Sustainability Report since January 2023 showcases the company’s commitment to creating a world with no healthcare limits Report shows reduced operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 Strong leadership focus on sustainability efforts and ESG with a cross-functional ESP GE HealthCare has released its inaugural Sustainability Report, marking its commitment to environmental, social, and governance (ESG) practices since becoming an independent company in January 2023. The report highlights the reduction of operational Scope 1 and 2 greenhouse gas emissions by 27% since 2019 and outlines the company's dedication to ESG principles and sustainability. GE HealthCare recognizes the importance of sustainability and corporate responsibility in the healthcare industry. The report reflects the company's dedication to creating a world where healthcare knows no limits and its commitment to environmental and social impact. ESG Program Leader at GE HealthCare, Kelvin Sanborn, stated, GE HealthCare recognizes the global significance of fulfilling our purpose and delivering on our objectives and is pleased to have reduced our operational GHG emissions by 27% versus our 2019 baseline. With our broad ESG strategy and priorities in mind, we are carrying out a climate risk assessment that will inform our climate transition plan, and developing a net zero roadmap for Scope 1, 2, and 3 GHG emissions. [Source: Business Wire] Key Highlights from the Company's Inaugural Sustainability Report: Environmental Impact Since 2019, reduced GHG emissions by 27% with goals of 50% reduction by 2030 and net zero by 2050 Registered with Science Based Targets Initiative Committed to decarbonizing the healthcare sector Social Impact Established cultural operating principles Planned GE Healthcare Foundation for philanthropy Appointed chief diversity, equity, and inclusion officer Governance and Accountability Strong corporate governance as a stand-alone public company Relaunched Code of Conduct with high employee engagement Joined UN Global Compact to support sustainable development goals GE HealthCare conducted an ESG materiality assessment, defining five key focus areas for its sustainability strategy. These include expanding healthcare access, fostering diversity and inclusion, reducing greenhouse gas emissions, promoting the circular economy, and enhancing patient data cybersecurity. The report outlines the company's long-term ESG objectives and progress toward previous goals. It is preparing to release an updated task force on climate-related financial disclosures (TCFD) report once its climate risk assessment is finalized. Furthermore, the company has scheduled a materiality assessment update for 2024. In parallel, GE HealthCare is exploring the expansion of Reporting Standards for its ESG disclosures and evaluating how its objectives align with the United Nations Sustainable Development Goals (UN SDGs). After conducting an ESG materiality assessment before its spin-off, the company has pinpointed five vital areas for its sustainability strategy. These priorities, underscored by the company's core innovation, product quality, and integrity principles, encompass the following: Expanding global healthcare access by ensuring underserved populations have better healthcare opportunities; promoting a culture of inclusion and diversity; mitigating its climate impact through concerted efforts; facilitating equipment and prioritizing patient data security and cybersecurity by adhering to standardized data privacy and security practices based on global regulations such as the EU GDPR.

Read More

Health Technology, Digital Healthcare

Johnson and Johnson Embraces New Era with Enhanced Visual Identity

Johnson and Johnson | September 15, 2023

Johnson and Johnson's brand identity communicates the company's bold healthcare innovation while staying true to its global patient care. Leveraging advanced medicine and technology, the company proactively tackles complex diseases with more innovative, less invasive, and personalized solutions. The company plans to gradually implement the new logo, colors, and font across all its materials, product packaging, and branding assets. Johnson and Johnson is currently revitalizing its brand and consolidating its MedTech and pharmaceutical segments under the unified name of Johnson and Johnson, demonstrating a steadfast commitment to healthcare innovation and addressing the most challenging health issues. The announcement signifies a pivotal moment in Johnson and Johnson's evolution as the company harnesses its extensive knowledge of innovative medicine and cutting-edge medical technology. This strategic move aims to proactively address, treat, and ultimately find cures for intricate diseases while simultaneously ushering in solutions characterized by heightened intelligence, reduced invasiveness, and greater personalization, marking a significant stride toward reshaping the future of healthcare. The company's two major segments will become more closely associated with the Johnson and Johnson brand. Over time, Janssen, the company's pharmaceutical part, will assume the name Johnson and Johnson Innovative Medicine, while the medical technology segment will retain the Johnson and Johnson MedTech designation. The pharmaceuticals segment leads the way in advancing healthcare, pioneering treatments to reshape the future of well-being. Johnson and Johnson Innovative Medicine combines a compassionate scientific approach to effectively confront the most complex diseases in oncology, immunology, neuroscience, cardiovascular, pulmonary hypertension, and retina to develop future medications. Simultaneously, the medical technology segment dedicates itself to addressing the most pressing healthcare challenges through innovations at the nexus of biology and technology. Vanessa Broadhurst, Executive Vice President of Global Corporate Affairs, stated, Our Johnson and Johnson brand identity communicates our bold approach to innovation in healthcare while staying true to the care we have for our patients around the world. [Source: Business Wire] The updated Johnson and Johnson logo, featuring letters drawn in a single stroke for added contrast and a sense of unexpectedness, embraces both long and short versions, with the 'J&J' abbreviation gaining prominence, especially in digital contexts. The color palette leans toward a refreshed and contemporary red, symbolizing the company's agility in responding to health challenges and evolving with the times. The revamped ampersand now signifies global recognition, openness, and the connections that breathe life into the brand's purpose. In terms of art direction, elements such as illustration and photography have undergone careful curation to evoke energy, optimism, and inclusivity, presenting a distinctive approach within the healthcare domain.

Read More